Electromed Stock Current Valuation
| ELMD Stock | USD 13.94 0.19 1.34% |
Valuation analysis of Electromed helps investors to measure Electromed's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The current year's Enterprise Value Over EBITDA is expected to grow to 17.06. The current year's Enterprise Value Multiple is expected to grow to 17.06. Fundamental drivers impacting Electromed's valuation include:
Price Book 3.1015 | Enterprise Value 109.6 M | Enterprise Value Ebitda 19.7326 | Price Sales 2.4204 | Trailing PE 30.9778 |
Undervalued
Today
Please note that Electromed's price fluctuation is somewhat reliable at this time. Calculation of the real value of Electromed is based on 3 months time horizon. Increasing Electromed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Electromed is useful when determining the fair value of the Electromed stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Electromed. Since Electromed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Electromed Stock. However, Electromed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 13.94 | Real 17.58 | Target 26.0 | Hype 14.1 |
The real value of Electromed Stock, also known as its intrinsic value, is the underlying worth of Electromed Company, which is reflected in its stock price. It is based on Electromed's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Electromed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Electromed's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Electromed helps investors to forecast how Electromed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Electromed more accurately as focusing exclusively on Electromed's fundamentals will not take into account other important factors: Electromed Company Current Valuation Analysis
Electromed's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Electromed Current Valuation | 109.65 M |
Most of Electromed's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Electromed is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Electromed Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Electromed is extremely important. It helps to project a fair market value of Electromed Stock properly, considering its historical fundamentals such as Current Valuation. Since Electromed's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Electromed's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Electromed's interrelated accounts and indicators.
Click cells to compare fundamentals
Electromed Current Valuation Historical Pattern
Today, most investors in Electromed Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Electromed's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Electromed current valuation as a starting point in their analysis.
Electromed Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Electromed has a Current Valuation of 109.65 M. This is 99.24% lower than that of the Health Care Equipment & Supplies sector and 99.12% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.34% higher than that of the company.
Electromed Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Electromed's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Electromed could also be used in its relative valuation, which is a method of valuing Electromed by comparing valuation metrics of similar companies.Electromed is currently under evaluation in current valuation category among related companies.
Electromed Current Valuation Drivers
We derive many important indicators used in calculating different scores of Electromed from analyzing Electromed's financial statements. These drivers represent accounts that assess Electromed's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Electromed's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 129.3M | 96.7M | 81.7M | 90.6M | 81.6M | 85.7M | |
| Enterprise Value | 118.9M | 84.9M | 73.6M | 83.4M | 75.1M | 78.8M |
Electromed Fundamentals
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0721 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 109.65 M | ||||
| Shares Outstanding | 8.61 M | ||||
| Shares Owned By Insiders | 26.69 % | ||||
| Shares Owned By Institutions | 32.78 % | ||||
| Number Of Shares Shorted | 42.93 K | ||||
| Price To Earning | 23.66 X | ||||
| Price To Book | 3.10 X | ||||
| Price To Sales | 2.42 X | ||||
| Revenue | 48.07 M | ||||
| Gross Profit | 36.52 M | ||||
| EBITDA | 4.62 M | ||||
| Net Income | 3.17 M | ||||
| Cash And Equivalents | 8.15 M | ||||
| Cash Per Share | 0.96 X | ||||
| Total Debt | 161 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 4.83 X | ||||
| Book Value Per Share | 4.69 X | ||||
| Cash Flow From Operations | 1.31 M | ||||
| Short Ratio | 1.06 X | ||||
| Earnings Per Share | 0.45 X | ||||
| Target Price | 26.0 | ||||
| Number Of Employees | 170 | ||||
| Beta | 0.42 | ||||
| Market Capitalization | 119.96 M | ||||
| Total Asset | 45.81 M | ||||
| Retained Earnings | 18.79 M | ||||
| Working Capital | 29.73 M | ||||
| Current Asset | 15.82 M | ||||
| Current Liabilities | 3.07 M | ||||
| Net Asset | 45.81 M |
About Electromed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Electromed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Electromed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Electromed based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Electromed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Electromed's short interest history, or implied volatility extrapolated from Electromed options trading.
Pair Trading with Electromed
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Electromed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Electromed will appreciate offsetting losses from the drop in the long position's value.Moving together with Electromed Stock
| 0.89 | FEMY | Femasys Financial Report 9th of May 2024 | PairCorr |
Moving against Electromed Stock
| 0.88 | IVP | Inspire Veterinary | PairCorr |
| 0.77 | TFX | Teleflex Incorporated Financial Report 2nd of May 2024 | PairCorr |
| 0.74 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
| 0.6 | DYNT | Dynatronics Financial Report 9th of May 2024 | PairCorr |
| 0.57 | AHG | Akso Health Group | PairCorr |
The ability to find closely correlated positions to Electromed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Electromed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Electromed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Electromed to buy it.
The correlation of Electromed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Electromed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Electromed moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Electromed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Electromed Piotroski F Score and Electromed Altman Z Score analysis. For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Electromed Stock analysis
When running Electromed's price analysis, check to measure Electromed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromed is operating at the current time. Most of Electromed's value examination focuses on studying past and present price action to predict the probability of Electromed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromed's price. Additionally, you may evaluate how the addition of Electromed to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is Electromed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Electromed. If investors know Electromed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Electromed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.727 | Earnings Share 0.45 | Revenue Per Share 6.072 | Quarterly Revenue Growth 0.167 | Return On Assets 0.0721 |
The market value of Electromed is measured differently than its book value, which is the value of Electromed that is recorded on the company's balance sheet. Investors also form their own opinion of Electromed's value that differs from its market value or its book value, called intrinsic value, which is Electromed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Electromed's market value can be influenced by many factors that don't directly affect Electromed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Electromed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Electromed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.